SCHEMBL19170366

SCHEMBL19170366

C1=Cc2ccccc2C2(c3ccccc31)c1ccccc1-c1cc(Nc3ccccc3-c3ccccc3)ccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FABP3 P05413 1/20 0.35
▸ FABP4 P15090 1/20 0.35
▸ FABP5 Q01469 1/20 0.35
▸ PDK2 Q15119 4/20 0.34
▸ AURKA O14965 1/20 0.33
▸ CDC25B P30305 1/20 0.33
▸ MAPK14 Q16539 2/20 0.32
▸ MAPK13 O15264 1/20 0.32
▸ MAPK12 P53778 1/20 0.32
▸ MAPK11 Q15759 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ MAPK10 P53779 1/20 0.32
▸ MYC P01106 1/20 0.31
▸ MAX P61244 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.30
▸ MEN1 O00255 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ LMNA P02545 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31650930 0.92 FABP3 (0.41) FABP3FABP4FABP5PDK2AURKA
SCHEMBL23288288 0.92 FABP3 (0.41) FABP3FABP4FABP5PDK2AURKA
SCHEMBL22662319 0.85 MEN1 (0.42) FABP3FABP4FABP5PDK2AURKA
SCHEMBL19170365 0.85 PDK2 (0.47) PDK2MAPK14ALDH1A1MEN1KMT2A
SCHEMBL29767840 0.83 PDK2 (0.44) FABP3FABP4FABP5PDK2AURKA
SCHEMBL796163 0.83 PDK2 (0.44) FABP3FABP4FABP5PDK2AURKA
SCHEMBL15892493 0.81 FABP3 (0.39) FABP3FABP4FABP5PDK2AURKA
SCHEMBL30132954 0.81 FABP3 (0.39) FABP3FABP4FABP5PDK2AURKA
SCHEMBL23561438 0.79 PDK2 (0.46) PDK2ALDH1A1MEN1KMT2ALMNA
SCHEMBL21368218 0.78 PDK2 (0.43) FABP3FABP4FABP5PDK2AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213972-A1 Novel compound and organic electronic device comprising the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213972-A1 Novel compound and organic electronic device comprising the same CHRM1, CHRM2, ESR1 FABP3 3996/4885FABP4 1730/4885FABP5 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback